Table 4: Hepcidin, CEA and CA19-9 levels in relapsed and non-relapsed patients.
|
|
Hepcidin (ng/ml) |
|||||||
|
|
Relapsed |
Non-Relapsed |
||||||
|
Mean |
76 |
36.6 |
||||||
|
Median |
89.45 |
27.5 |
||||||
|
Std. Deviation |
35.3 |
28.8 |
||||||
|
Minimum |
15.4 |
5.6 |
||||||
|
Maximum |
109.3 |
101.4 |
||||||
|
P-value* |
0.001 |
|||||||
|
*Shapiro-Wilk test |
||||||||
|
|
|
Mean |
Median |
SD |
Min |
Max |
p-value |
|
|
CEA |
Non-relapsed |
20.8 |
17 |
14 |
0.9 |
47.7 |
0.465 |
|
|
|
Relapsed |
26.1 |
31 |
17.2 |
1.4 |
47.8 |
||
|
CA19-9 |
Non-relapsed |
15.1 |
9.9 |
12.4 |
1.2 |
44.9 |
0.251 |
|
|
|
Relapsed |
22.9 |
17 |
18.4 |
2.2 |
47.8 |
||